ASGCT information: Chatter about Vinay Prasad, and new child screening
NEW ORLEANS — Greetings from the house stretch of American Society of Gene and Cell Remedy convention, the place everybody remains to be speaking about Child KJ and nobody desires to speak about Vinay Prasad.
The Vinay Prasad within the room
Final yr, a whole lot of individuals poured in to see Peter Marks, the FDA’s head of biologics, communicate at at ASGCT. The regulator was seen by many advocates, researchers and executives as an ally of their efforts to get uncommon illness therapies authorized, generally regardless of restricted or contradictory proof.
Now, after all, Marks has been fired by the Trump administration. And among the many greatest questions going through the gene remedy subject is what stance Vinay Prasad, the fiery hematologist and oft-pharma critic who changed him, will take towards such uncommon illness therapies.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
